John, King of England of the United Kingdom. John, the youngest of five sons of King Henry II of England and Duchess Eleanor of Aquitaine, was at first not expected to inherit significant lands. Following the failed rebellion of his elder brothers between 1173 and 1174, however, John became Henry's favourite child. He was appointed the Lord of Ireland in 1177 and given lands in England and on the continent. John's elder brothers William, Henry and Geoffrey died young; by the time Richard I became king in 1189, John was a potential heir to the throne. John unsuccessfully attempted a rebellion against Richard's royal
King Pharmaceuticals Inc. was incorporated in the State of Tennessee in 1993. According to the King Pharmaceutcals, Inc. Form 10-K for the year ended December 31, 2007 filed with the U.S. Securities and Exchange Commission, the wholly owned subsidiaries of King Pharmaceuticals, Inc. are Monarch Pharmaceuticals, Inc.; King Pharmaceuticals Research and Development, Inc.; Meridian Medical Technologies, Inc.; Parkedale Pharmaceuticals, Inc.; King Pharmaceuticals Canada Inc.; and Monarch Pharmaceuticals Ireland Limited. King Pharmaceuticals was founded in 1993 John M. Gregory, Randal J. Kirk, Joseph "Joe" R. Gregory, Jefferson "Jeff" J. Gregory, and James E. Gregory. In January 1994, King acquired a former King College